800 related articles for article (PubMed ID: 15928024)
1. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle.
Carvalho E; Kotani K; Peroni OD; Kahn BB
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E551-61. PubMed ID: 15928024
[TBL] [Abstract][Full Text] [Related]
2. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.
Gnudi L; Tozzo E; Shepherd PR; Bliss JL; Kahn BB
Endocrinology; 1995 Mar; 136(3):995-1002. PubMed ID: 7867610
[TBL] [Abstract][Full Text] [Related]
3. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.
Kim JK; Zisman A; Fillmore JJ; Peroni OD; Kotani K; Perret P; Zong H; Dong J; Kahn CR; Kahn BB; Shulman GI
J Clin Invest; 2001 Jul; 108(1):153-60. PubMed ID: 11435467
[TBL] [Abstract][Full Text] [Related]
4. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
Kotani K; Peroni OD; Minokoshi Y; Boss O; Kahn BB
J Clin Invest; 2004 Dec; 114(11):1666-75. PubMed ID: 15578099
[TBL] [Abstract][Full Text] [Related]
5. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver.
Abel ED; Peroni O; Kim JK; Kim YB; Boss O; Hadro E; Minnemann T; Shulman GI; Kahn BB
Nature; 2001 Feb; 409(6821):729-33. PubMed ID: 11217863
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.
Zisman A; Peroni OD; Abel ED; Michael MD; Mauvais-Jarvis F; Lowell BB; Wojtaszewski JF; Hirshman MF; Virkamaki A; Goodyear LJ; Kahn CR; Kahn BB
Nat Med; 2000 Aug; 6(8):924-8. PubMed ID: 10932232
[TBL] [Abstract][Full Text] [Related]
7. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
Yang Q; Graham TE; Mody N; Preitner F; Peroni OD; Zabolotny JM; Kotani K; Quadro L; Kahn BB
Nature; 2005 Jul; 436(7049):356-62. PubMed ID: 16034410
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter.
Tozzo E; Gnudi L; Kahn BB
Endocrinology; 1997 Apr; 138(4):1604-11. PubMed ID: 9075721
[TBL] [Abstract][Full Text] [Related]
9. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.
Rossetti L; Stenbit AE; Chen W; Hu M; Barzilai N; Katz EB; Charron MJ
J Clin Invest; 1997 Oct; 100(7):1831-9. PubMed ID: 9312184
[TBL] [Abstract][Full Text] [Related]
10. Lilly lecture 1995. Glucose transport: pivotal step in insulin action.
Kahn BB
Diabetes; 1996 Nov; 45(11):1644-54. PubMed ID: 8866574
[TBL] [Abstract][Full Text] [Related]
11. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4.
Katz EB; Stenbit AE; Hatton K; DePinho R; Charron MJ
Nature; 1995 Sep; 377(6545):151-5. PubMed ID: 7675081
[TBL] [Abstract][Full Text] [Related]
12. GLUT4: a key player regulating glucose homeostasis? Insights from transgenic and knockout mice (review).
Wallberg-Henriksson H; Zierath JR
Mol Membr Biol; 2001; 18(3):205-11. PubMed ID: 11681787
[TBL] [Abstract][Full Text] [Related]
13. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats.
Park SY; Choi GH; Choi HI; Ryu J; Jung CY; Lee W
Arch Biochem Biophys; 2005 Apr; 436(2):276-84. PubMed ID: 15797240
[TBL] [Abstract][Full Text] [Related]
14. Effects of hyperglycemia on glucose transporters of the muscle: use of the renal glucose reabsorption inhibitor phlorizin to control glycemia.
Dimitrakoudis D; Vranic M; Klip A
J Am Soc Nephrol; 1992 Nov; 3(5):1078-91. PubMed ID: 1482748
[TBL] [Abstract][Full Text] [Related]
15. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes.
Stenbit AE; Tsao TS; Li J; Burcelin R; Geenen DL; Factor SM; Houseknecht K; Katz EB; Charron MJ
Nat Med; 1997 Oct; 3(10):1096-101. PubMed ID: 9334720
[TBL] [Abstract][Full Text] [Related]
16. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle.
Tsao TS; Burcelin R; Katz EB; Huang L; Charron MJ
Diabetes; 1996 Jan; 45(1):28-36. PubMed ID: 8522056
[TBL] [Abstract][Full Text] [Related]
17. Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes.
Miura T; Suzuki W; Ishihara E; Arai I; Ishida H; Seino Y; Tanigawa K
Eur J Endocrinol; 2001 Dec; 145(6):785-90. PubMed ID: 11720905
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of insulin resistance but not hyperinsulinemia in obese mice overexpressing GLUT4 selectively in skeletal muscle.
Tsao TS; Katz EB; Pommer D; Charron MJ
Metabolism; 2000 Mar; 49(3):340-6. PubMed ID: 10726912
[TBL] [Abstract][Full Text] [Related]
19. Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle.
Tsao TS; Stenbit AE; Factor SM; Chen W; Rossetti L; Charron MJ
Diabetes; 1999 Apr; 48(4):775-82. PubMed ID: 10102694
[TBL] [Abstract][Full Text] [Related]
20. Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat.
Hamann A; Benecke H; Le Marchand-Brustel Y; Susulic VS; Lowell BB; Flier JS
Diabetes; 1995 Nov; 44(11):1266-73. PubMed ID: 7589822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
